DEA DIVERSION THE NEW PHARMACEUTICAL ROADBLOCK: Take the case of MMJ’s …

MMJ BioPharma Cultivation-despite securing FDA Investigational New Drug (IND) approvals and Orphan Drug Designation for treating Huntington’s Disease- …